Strides Pharma Science schedules Mumbai investor meet for Q4FY26

0 min read     Updated on 09 Jun 2026, 01:26 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Strides Pharma Science Limited announced a Non-Deal Road Show in Mumbai on June 12, 2026, hosted by DAM Capital. The in-person meeting will review Q4FY26 financial performance based on the earnings presentation uploaded on May 18, 2026.

powered bylight_fuzz_icon
41538687

*this image is generated using AI for illustrative purposes only.

Strides Pharma Science Limited will host a Non-Deal Road Show in Mumbai on June 12, 2026, to discuss its financial performance for the quarter ended March 31, 2026. Hosted by DAM Capital, this in-person session allows analysts and institutional investors to review the company's Q4FY26 results. The discussion will be based on the earnings presentation previously uploaded to the stock exchanges and company website on May 18, 2026.

The meeting is scheduled to commence at 10:00 hrs and will be conducted in a one-on-one format. This engagement provides a platform for management to present the business outlook and quarterly findings directly to stakeholders.

Date & Time Event Type Mode/ Type of Meeting Location
June 12, 2026
from 10:00 hrs onwards
Non-Deal Road Show
hosted by DAM Capital
In-person
(One-on-One)
Mumbai,
India

Manjula Ramamurthy, Company Secretary & Compliance Officer, signed the disclosure regarding the meeting on June 8, 2026.

Historical Stock Returns for Strides Pharma Science

1 Day5 Days1 Month6 Months1 Year5 Years
-0.45%+2.39%-3.64%+16.60%+33.90%+226.36%

What specific growth drivers does Strides Pharma anticipate for the upcoming fiscal year following the Q4FY26 review?

How might the insights shared during this roadshow influence institutional investor sentiment towards the stock?

What are the expected market reactions to the company's business outlook presented during the one-on-one sessions?

like20
dislike

Strides Pharma Science Limited reminds shareholders to claim unclaimed dividends

1 min read     Updated on 02 Jun 2026, 04:44 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Strides Pharma Science Limited issued a notice reminding shareholders to claim unclaimed dividends from 2018-19 and 2019-20 by September 3, 2026. Unclaimed dividends and the corresponding shares will be transferred to the Investor Education and Protection Fund if not claimed. Shareholders can find details on the company website or contact KFin Technologies Limited for assistance.

powered bylight_fuzz_icon
41944425

*this image is generated using AI for illustrative purposes only.

Strides Pharma Science Limited has notified shareholders that unclaimed dividends for the financial years 2018-19 and 2019-20 are due for transfer to the Investor Education and Protection Fund (IEPF). The company dispatched reminder letters to affected shareholders whose dividends have remained unclaimed for a period of seven consecutive years, urging them to claim the funds before the deadline to avoid the forfeiture of shares.

Transfer of Unclaimed Dividends

Pursuant to Section 124(6) of the Companies Act, 2013 and the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, the company is required to transfer unclaimed amounts to the IEPF. The specific dividends identified for transfer include the Final Dividend for 2018-19 and the Interim Dividend for 2019-20.

Dividend Type Year Due Date for Transfer
Final Dividend 2018-19 September 4, 2026
Interim Dividend 2019-20 September 3, 2026

Shareholder Action Required

The company emphasized that shareholders must claim their unpaid dividends on or before September 3, 2026. Failure to do so will result in the transfer of the corresponding shares, whether held in physical or electronic form, to the designated demat account of the IEPF Authority. Once transferred, shareholders can claim both the shares and dividends from the IEPF, though the process involves specific procedures outlined by the authority.

Contact Information

Shareholders seeking clarification or assistance regarding the claim process can contact the company or its registrar, KFin Technologies Limited. The list of shares liable for transfer has been updated on the company’s website for reference.

Historical Stock Returns for Strides Pharma Science

1 Day5 Days1 Month6 Months1 Year5 Years
-0.45%+2.39%-3.64%+16.60%+33.90%+226.36%

How will the potential transfer of shares to the IEPF impact Strides Pharma's shareholder base and liquidity?

What measures is Strides Pharma taking to improve dividend awareness and reduce unclaimed dividends in the future?

Could the forfeiture of shares to the IEPF lead to any changes in the company's corporate governance or dividend distribution policies?

like20
dislike

More News on Strides Pharma Science

1 Year Returns:+33.90%